This role has been debated, and in 2018, Booth et al. [24] described a cohort of patients affected by non-syndromic hearing loss (NSHL) related to pathogenic variants in CIB2, without any evidence of retinal dystrophy. This evidence concerns the gene CIB2 and nodular sclerosis classical Hodgkin lymphoma.